Whole Body Vibration Training Applied with Different Frequencies in Hypertensive Patients
Investigation of the Effects of Single Session Whole Body Vibration Training Applied with Different Frequencies in Hypertensive Patients
1 other identifier
interventional
36
1 country
1
Brief Summary
At least 36 volunteers with a diagnosis of hypertension in the Department of Cardiology of Dokuz Eylul University and who meet the criteria for follow-up and inclusion will participate in the study. The aim of this study is to compare the acute effects on atherosclerosis, heart rate variability, blood pressure, perceived exertion, energy expenditure, and muscle strength of using different frequencies in whole body vibration training (WBVT) in hypertensive patients. Individuals will perform; static squat, dynamic toe raise, static abduction and dynamic squat exercises in both hips on a vibrating platform. In each session, a different frequency (0,25 and 40 Hz) will be applied. 0 Hz, 25 Hz and 40 Hz sessions will be randomized to last 15 minutes. Demographic and clinical information of the participants will be questioned.Before and after the sessions; hemodynamic and pulmonary responses, vascular responses, heart rate variability and quadriceps femoris muscle strength will be measured. In addition, energy expenditure will be recorded during the sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Oct 2022
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 14, 2022
CompletedFirst Submitted
Initial submission to the registry
February 23, 2023
CompletedFirst Posted
Study publicly available on registry
March 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2023
CompletedNovember 20, 2024
May 1, 2023
8 months
February 23, 2023
November 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Arterial stiffness
Arterial stiffness will be measured with a noninvasive method with the help of the SphygmocorXCEL device, which can automatically measure with the cuff. The patient's age(years), gender(male), blood pressure(mmHg), height(cm), weight(kg), carotid-sternal notch distance between the artery, carotid-femoral artery as the distance between the entered data to the computer after increasing pressure over the brachial artery through a transducer (augmentation index) and again, carotid-femoral pulse wave velocity via the artery (pulse wave velocity) measurements will be made.
Change from the baseline to the first minutes after the intervention
Heart rate variability
Heart rate variability will be assessed by heart rate variability (HRV), a non-invasive measurement. Sympathetic and parasympathetic autonomic function will be evaluated with HRV software. HRV provides time and frequency domain parameters associated with autonomic function.
Change from the baseline to the first minutes after the intervention
Blood pressure
Systolic and diastolic blood pressure will be measured with a sphygmomanometer.
Change from the baseline to the first minutes after the intervention
Secondary Outcomes (5)
Muscle strength
Change from the baseline to the first minutes after the intervention
Energy expenditure
During exercise intervention, average 15 minutes
Heart rate
Change from the baseline to the first minutes after the intervention
Perceived effort
Change from the baseline to the first minutes after the intervention
Respiratory frequency
Change from the baseline to the first minutes after the intervention
Study Arms (3)
Whole body vibration intervention at 40 Hz
ACTIVE COMPARATOR40 Hz frequency WBVT
Whole body vibration intervention at 25 Hz
ACTIVE COMPARATOR25 Hz frequency WBVT
Whole body vibration intervention at 0 Hz
ACTIVE COMPARATOR0 Hz frequency WBVT
Interventions
Whole body vibration intervention will be performed with the Power Plate Pro 5 device (Power Plate International, London, UK). Whole body vibration training will be performed at a frequency of 40 Hz. Individuals will perform; static squat, dynamic toe raise, static abduction and dynamic squat exercises in both hips on a vibrating platform. All exercises will consist of 45 seconds of vibration and 15 seconds of rest. Each exercise will be repeated three times. Total intervention time will be 15 minutes.
Whole body vibration intervention will be performed with the Power Plate Pro 5 device (Power Plate International, London, UK). Whole body vibration training will be performed at a frequency of 25 Hz. Individuals will perform; static squat, dynamic toe raise, static abduction and dynamic squat exercises in both hips on a vibrating platform. All exercises will consist of 45 seconds of vibration and 15 seconds of rest. Each exercise will be repeated three times. Total intervention time will be 15 minutes.
Whole body vibration intervention will be performed with the Power Plate Pro 5 device (Power Plate International, London, UK). Whole body vibration training will be performed at a frequency of 0 Hz. Individuals will perform; static squat, dynamic toe raise, static abduction and dynamic squat exercises in both hips on a vibrating platform. All exercises will consist of 45 seconds of vibration and 15 seconds of rest. Each exercise will be repeated three times. Total intervention time will be 15 minutes.
Eligibility Criteria
You may qualify if:
- Being diagnosed with hypertension
- Being clinically stable
- Becoming a volunteer
- Walking independently
- Not taking medication or hormone therapy in the year before the study
- Lack of regular exercise habit (\<60 minutes/week of exercise)
You may not qualify if:
- Having a serious cardiovascular/pulmonary condition
- Having an operation in the last 6 months
- Presence of acute thrombosis
- Presence of arrhythmia
- Presence of unstable angina
- Recent decompensated heart failure
- Recent myocardial infarction
- Using an assistive device to walk
- Neurological disorders (such as stroke, Parkinson's)
- Being diagnosed with vertigo
- Being diagnosed with epilepsy
- Kidney failure and history of kidney stones
- Hip or knee implants
- Recent fractures or injuries (\<6 months).
- Using a prosthesis
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dokuz Eylül University
Izmir, Balçova, 35140, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sema Savcı
Dokuz Eylul University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Master of Science
Study Record Dates
First Submitted
February 23, 2023
First Posted
March 14, 2023
Study Start
October 14, 2022
Primary Completion
June 13, 2023
Study Completion
June 21, 2023
Last Updated
November 20, 2024
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share